Given that ATMPs—as well as affected person journeys related with them—are fundamentally unique from standard biopharmaceuticals, developing and conducting trials of such novel therapeutics will involve one of a kind regulatory and clinical factors. in the following paragraphs, we explore tactics for successful commence-up and execution of ATMP